Vanguard Fiduciary Trust’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$672K Sell
63,337
-3,703
-6% -$42.7K ﹤0.01% 3173
2026
Q1
$683K Buy
+67,040
New +$723K ﹤0.01% 3096

Other funds holding MED

Vanguard Fiduciary Trust's MED Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Medifast (MED) stake by 5.5% in Q2 2026, selling an estimated $42.7K and leaving 63,337 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Vanguard Fiduciary Trust first reported a position in MED in Q1 2026 and has held it in 2 quarters since. The position peaked at $683K in Q1 2026. 111 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Vanguard Fiduciary Trust held 63,337 shares of Medifast worth $672K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 3,703 Medifast shares in Q2 2026, an estimated $42.7K.
  • Medifast made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3173 holding.
  • Vanguard Fiduciary Trust first reported a position in Medifast in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Medifast position peaked at $683K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.